Serum Vitamin B12, Homocysteine and Methylmalonic Acid Levels in Patients With Parenchymal Neuro-Behçet’s Syndrome

Objectives: This study aims to investigate the role of serum levels of vitamin B12 (VitB12), homocysteine (Hcy), and methylmalonic acid (MMA) in the development of parenchymal neuro-Behçet’s syndrome (NBS) and to compare them with healthy controls and Behçet’s syndrome (BS) patients without NBS.Patients and methods: Serum VitB12, Hcy, and MMA were measured using enzyme-linked immunosorbent assay in 64 patients (36 males, 28 females; mean age 36±8.3 years; range 20 to 56 years) who met the criteria of the International Study Group for Behçet’s Disease and 30 matched healthy controls (17 males, 13 females; mean age 35.76±9.6 years; range 20 to 50 years). The study participants were grouped as BS patients with NBS, BS patients without NBS, and healthy controls.Results: There was no significant difference between the groups regarding serum VitB12, Hcy, and MMA levels (p>0.05). Serum VitB12 levels were below the lower limit and serum Hcy levels were above the upper limit in all participants. MMA levels were normal in all participants. There was no correlation between the serum levels of VitB12, Hcy, and MMA and disease activity (p>0.05).Conclusion: The results of this study suggest that there is no significant association between VitB12 deficiency and parenchymal NBS. Further studies are needed to investigate the underlying mechanisms of the variable effects of VitB12 deficiency on different clinical manifestations of BS

Kaynakça

1. Akman-Demir G, Serdaroglu P, Tasçi B. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The NeuroBehçet Study Group. Brain 1999;122:2171-82.

2. Siva A, Kantarci OH, Saip S, Altintas A, Hamuryudan V, Islak C, et al. Behçet’s disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 2001;248:95-103.

3. Healton EB, Savage DG, Brust JC, Garrett TJ, Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medicine (Baltimore) 1991;70:229-45.

4. Leishear K, Boudreau RM, Studenski SA, Ferrucci L, Rosano C, de Rekeneire N, et al. Relationship between vitamin B12 and sensory and motor peripheral nerve function in older adults. J Am Geriatr Soc 2012;60:1057-63.

5. van Overbeek EC, Staals J, van Oostenbrugge RJ. Vitamin B12 and progression of white matter lesions. A 2-year follow-up study in first-ever lacunar stroke patients. PLoS One 2013;8:78100.

6. Martin DC, Francis J, Protetch J, Huff FJ. Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study. J Am Geriatr Soc 1992;40:168-72.

7. Tefferi A, Pruthi RK. The biochemical basis of cobalamin deficiency. Mayo Clin Proc 1994;69:181-6.

8. Lindenbaum J, Savage DG, Stabler SP, Allen RH. Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am J Hematol 1990;34:99-107.

9. Matchar DB, McCrory DC, Millington DS, Feussner JR. Performance of the serum cobalamin assay for diagnosis of cobalamin deficiency. Am J Med Sci 1994;308:276-83.

10. Criteria for diagnosis of Behçet’s disease. International Study Group for Behçet’s Disease. Lancet 1990;335:1078-80.

11. Kumar N. Neurologic aspects of cobalamin (B12) deficiency. Handb Clin Neurol 2014;120:915-26.

12. Stabler SP. Screening the older population for cobalamin (vitamin B12) deficiency. J Am Geriatr Soc 1995;43:1290-7.

13. Snow CF. Laboratory diagnosis of vitamin B12 and folate deficiency: a guide for the primary care physician. Arch Intern Med 1999;159:1289-98.

14. Solomon LR. Cobalamin-responsive disorders in the ambulatory care setting: unreliability of cobalamin, methylmalonic acid, and homocysteine testing. Blood 2005;105:978-85.

15. Locatelli ER, Laureno R, Ballard P, Mark AS. MRI in vitamin B12 deficiency myelopathy. Can J Neurol Sci 1999;26:60-3.

16. Taysi S, Sari RA, Dursun H, Yilmaz A, Keles M, Cayir K, et al. Evaluation of nitric oxide synthase activity, nitric oxide, and homocysteine levels in patients with active Behcet’s disease. Clin Rheumatol 2008;27:1529-34.

17. Ozkan Y, Yardim-Akaydin S, Sepici A, Engin B, Sepici V, Simek B. Assessment of homocysteine, neopterin and nitric oxide levels in Behçet’s disease. Clin Chem Lab Med 2007;45:73-7.

18. Aksu K, Turgan N, Oksel F, Keser G, Ozmen D, Kitapçio¤lu G, et al. Hyperhomocysteinaemia in Behçet’s disease. Rheumatology (Oxford) 2001;40:687-90.

19. La Regina M, Orlandini F, Prisco D, Dentali F. Homocysteine in vascular Behcet disease: a meta-analysis. Arterioscler Thromb Vasc Biol 2010;30:2067-74.

20. Ate A, Aydintu¤ O, Olmez U, Düzgün N, Duman M. Serum homocysteine level is higher in Behçet’s disease with vascular involvement. Rheumatol Int 2005;25:42-4.

21. Feng L, Isaac V, Sim S, Ng TP, Krishnan KR, Chee MW. Associations between elevated homocysteine, cognitive impairment, and reduced white matter volume in healthy old adults. Am J Geriatr Psychiatry 2013;21:164-72.

22. Tascilar K, Melikoglu M, Ugurlu S, Sut N, Caglar E, Yazici H. Vascular involvement in Behçet’s syndrome: a retrospective analysis of associations and the time course. Rheumatology (Oxford) 2014;53:2018-22.

23. Undas A, Brozek J, Szczeklik A. Homocysteine and thrombosis: from basic science to clinical evidence. Thromb Haemost 2005;94:907-15.

24. Ansari R, Mahta A, Mallack E, Luo JJ. Hyperhomocysteinemia and neurologic disorders: a review. J Clin Neurol 2014;10:281-8.

25. Lindenbaum J, Healton EB, Savage DG, Brust JC, Garrett TJ, Podell ER, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988;318:1720-8.

Kaynak Göster

Archives of Rheumatology
  • ISSN: 2148-5046
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 2014

7.6b4.9b

Sayıdaki Diğer Makaleler

Prevalence and Metabolic Factors of Hyperuricemia in an Elderly Agricultural and Fishing Population in Taiwan

Qian YU

Serum Vitamin B12, Homocysteine and Methylmalonic Acid Levels in Patients With Parenchymal Neuro-Behçet’s Syndrome

Berivan BİTİK, ABDURRAHMAN TUFAN, Sehri ELBEG, RIDVAN MERCAN, Hamit KÜÇÜK, ORHAN KÜÇÜKŞAHİN, MEHMET AKİF ÖZTÜRK, ŞEMİNUR HAZNEDAROĞLU, BERNA GÖKER

Deep Vein Thrombosis as a Rare Presentation in a Female With Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis

Wan Syamimee WAN GHAZALI, Nurashikin MOHAMMAD, Asmahan Mohd ISMAIL

Rectal Adenocarcinoma as an Uncommon Cause of Immunoglobulin A Vasculitis (Henoch-Schönlein Purpura)

Ahmet OMMA, Mehmet Emin ENECİK, Zeynep ÖZBALKAN, Sevinç Can SANDIKÇI, Yaşar KARAASLAN

Survival Analysis of Turkish Patients With Systemic Lupus Erythematosus: Older Age at Diagnosis Affects Mortality

Döndü Üsküdar CANSU, Hava Üsküdar TEKE, Cengiz KORKMAZ

Mechanism of TRPA1 and TRPV4 Participating in Mechanical Hyperalgesia of Rat Experimental Knee Osteoarthritis

Peimin WANG, Linrui ZHAO, Bo XU, Nongshan ZHANG, Xiaochen LI

Primary Sjögren’s Syndrome Adversely Affects the Female Sexual Function Assessed by the Female Sexual Function Index: A Case-Control Study

Çağlar YILDIZ, Savaş KARAKUŞ, Özlem BOZOKLU AKKAR, ALİ ŞAHİN, Birkan BOZKURT, ALİ YANIK

Erdheim-Chester Disease With Renal Involvement: A Case Report

Ali Kürşat GANİYUSUFOĞLU, Gökşen GÖKŞENOĞLU, Burçin TUNÇ, Nurdan PAKER

Decrease of Serum IGF-1 Level is not Associated With Obstructive Sleep Apnea in Fibromyalgia Patients

Emrullah HAYTA, Ayşe Altun OKŞAŞOĞLU

Can Pentraxin-3 be a Candidate Marker in the Follow-Up of the Patients With Behçet’s Disease?

Banu ALPASLAN MESCİ, Banu İŞBİLEN BAŞOK, Hatice GÜL SAĞUN, Gökhan GÖNENLİ, Mukaddes KAVALA, Esen KASAPOĞLU GÜNAL, Esra EKİZ, FERRUH KEMAL İŞMAN, AYTEKİN OĞUZ